Appraising the causal relevance of DNA methylation for risk of lung cancer
Thomas Battram(University of Bristol), Caroline L. Relton(Newcastle College), Gibran Hemani(Bristol City Council), Graham G. Giles(The University of Melbourne), Florence Guida(Centre international de recherche sur le cancer), Vittorio Perduca(Délégation Paris 5), Mattias Johansson(Centre international de recherche sur le cancer), Tom R. Gaunt(MRC Epidemiology Unit), Silvia Polidoro(Cancer Prevention Institute of California), Rayjean J. Hung, Philip Haycock(University of Bristol), Therese Haugdahl Nøst(UiT The Arctic University of Norway), Rebecca C. Richmond(John Radcliffe Hospital), Kjell Grankvist(Umeå University), Stig E. Bojesen(University of Copenhagen), Robert Carreras‐Torres(Institut de Biologia Evolutiva), Børge G. Nordestgaard(Gentofte Hospital), Tm Sandanger(UiT The Arctic University of Norway), Paolo Vineis(Imperial College London), Gianluca Severi(Inserm), JR Freeman, CI Amos(Dartmouth College), AE Teschendorff(Chinese Academy of Sciences), George Davey Smith(University of Bristol), MB Johansson(Centre international de recherche sur le cancer), Laura Baglietto
Cited by 13
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k